氨酸-凝等级水凝用于骨质疏松性骨缺陷修复
Yanyu Ma1, Haiwen Su2, Wenhan Li3
1Division of Spine Surgery, Department of Orthopedic Surgery, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing 210008, China.
International journal of biological macromolecules
|July 12, 2024
概括
这项研究引入了一种新的水凝,用于治疗骨质疏松性骨缺陷. 开发的材料有效促进骨再生,提供了一个有前途的新疗法候选者.
科学领域:
- 生物材料科学 生物材料科学
- 再生医学是一种再生医学.
- 整形外科 整形外科 整形外科
背景情况:
- 骨质疏松性骨缺陷在治疗中存在重大挑战,原因是骨质不佳和复发率高.
- 现有的治疗方法往往难以有效,导致社会经济负担很大.
- 迫切需要先进的治疗策略来有效修复和重建这些骨缺陷.
研究的目的:
- 开发和评估一种用于治疗骨质疏松性骨缺陷的新型层次水凝系统.
- 在临床前模型中研究水凝的骨质生成潜力和治疗疗效.
主要方法:
- 用阿伦德罗纳酸 (AS) 和Mg2+ (IOHM-AS-Mgs) 装载的逆光甲基烯酸凝 (GelMA) 水凝微球的制造.
- 将IOHM-AS-Mgs纳入甲基化聚乙烯酸 (HAMA) 矩阵中,用于现场应用.
- 使用微型CT和组织学分析评估细胞相容性,细胞粘附,骨质刺激 (转录和蛋白质水平) 和体内治疗效果.
主要成果:
- 开发的IOHM-AS-Mgs水凝微球显示出出色的细胞兼容性,并促进了显著的细胞粘附.
- 在转录和蛋白质表达水平上观察到强烈的骨质生成刺激.
- 在骨质疏松性骨缺陷区域的体内研究显示,与对照组相比,等级水凝的治疗效果优越.
结论:
- 分层水凝,包括AS/Mg2+载荷的IOHM-AS-Mgs在HAMA矩阵内,是一种高度有效的治疗骨质疏松性骨缺陷的方法.
- 这种先进的水凝系统显示出促进骨再生和重建的巨大潜力.
- 开发的水凝是临床应用的有希望的新候选者,用于治疗具有挑战性的骨缺陷.
相关概念视频
01:27Fractures: Bone Repair
Treatment for a fracture is based on the type of break, the bone affected, and the patient's age.
Minor fractures with no bone displacement are treated by immobilizing the fractured bone using a cast or splint. However, in the case of fractures with displaced bones, the broken bones are repositioned before immobilization to ensure successful healing without deformation and loss of function. The realignment of fractured bone ends is performed through a process called reduction. If the procedure...
Minor fractures with no bone displacement are treated by immobilizing the fractured bone using a cast or splint. However, in the case of fractures with displaced bones, the broken bones are repositioned before immobilization to ensure successful healing without deformation and loss of function. The realignment of fractured bone ends is performed through a process called reduction. If the procedure...
01:31Bone Remodeling and Repair
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during bone...